Tag: supreme court
Maryland has some of the toughest gun laws in the country, including a ban on assault weapons.
There’s a reason there are supposed to be an odd number of judges serving on the Supreme Court.
Our busy Supreme Court handed down another monumental ruling this week kicking back the Environmental Protection Agency’s (EPA) first stab at reducing coal-fired electricity mercury pollution.
This SCOTUS ruling may seem wonky, even a little boring, but setting ‘acceptable’ levels of pollution (isn’t that an oxymoron?) is critical for health, and also for our climate. It’s also interesting to understand how big federal emissions regulations play out locally in Charm City’s own coal-fired power plants, and the air you and your family breathe.
Last week, Supreme Court Chief Justice John Roberts showed up in a Maryland courtroom… but not necessarily in the capacity you might expect.
Thanks to yesterday’s Supreme Court ruling invalidating the federal Defense of Marriage Act, same-sex couples who are married are one step closer to receiving federal benefits. And since Maryland legalized same-sex marriage last November, this state’s celebrations were especially sweet. But that didn’t stop Baltimore Archbishop William Lori from raining on the parade.
Baltimore Fishbowl student intern Ethan Park had the privilege last week to hear attorneys argue the case over gene patents before the United States Supreme Court.
Recently, in the landmark case AMP v. Myriad Genetics, the justices of the U.S. Supreme Court have endeavored to resolve the question: Are human genes patentable?
Last year, the U.S. Court of Appeals for the Federal Circuit ruled that Myriad Genetics’ patents directed to the BRCA1 and BRCA2 genes, whose variants are associated with an increased risk of developing breast and ovarian cancer, are patentable subject matter.
The Association for Molecular Pathology (AMP) appealed to the Supreme Court, oral arguments were made just over a week ago before a packed courtroom, and a verdict is expected in June or July.
Patents expire 20 years from the filing date, and patent protection for the BRCA genes has given Myriad a monopoly over BRCA testing procedures, which brings in millions of dollars annually for the company. Myriad also has the right to deny competitors or individuals from further researching or producing the genes without their consent.